中医药在肝癌介入术后的临床应用现状Application status of TCM after interventional therapy of liver cancer
苏凯奇;林柳兵;陈懿榕;沈艳婷;李勇;
摘要(Abstract):
对近5年已发表的关于中医药在肝癌介入术后的临床应用研究进行归纳总结。中医药广泛应用于肝癌介入术后治疗中,主要在改善肝癌介入术后患者胃肠道反应、保护肝功能、减轻骨髓抑制、缓解术后疼痛、调节免疫功能以及延长患者生存期等方面具有一定的优势。
关键词(KeyWords): 肝癌;中医药;不良反应;生存期
基金项目(Foundation): 国家自然科学基金(81573775);; 上海市卫生系统百人计划基金(XBR2013120);; 上海市科学技术委员会(15401930700)
作者(Author): 苏凯奇;林柳兵;陈懿榕;沈艳婷;李勇;
Email:
DOI: 10.13463/j.cnki.jlzyy.2018.12.032
参考文献(References):
- [1]KUDO M.Molecular targeted therapy for hepatocellular carcinoma:bench to bedside[J].Dig Dis,2011,29(3):273-277.
- [2]左婷婷,郑荣寿,曾红梅,等.中国肝癌发病现状与趋势分析[J].中华肿瘤杂志,2015,37(9):691-696.
- [3]KARIM M,ROBERT B,MOHAMED A,et al.Analysis of survival predictors in a porspective cohort of patients undergoing transarterial chemoembolization for hepatocellular carcinoma in a single Candian centre[J].HPB,2012(14):162-170.
- [4]ZHAI XF,CHEN Z,LI B,et al.Traditional herbal medicine in preventing recurrence after resection of small hepatocellular carcinoma:a multicenter randomized controlled trial[J].Journal of Integrative Medicine,2013,11(2):90-100.
- [5]QI F,ZHAO L,ZHOU A,et al.The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer[J].Bioscience trends,2015,9(1):16-34.
- [6]QI F,LI A,INAGAKI Y,et al.Chinese herbal medicines as adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer[J].Bioscience trends,2010,4(6):297-307.
- [7]SUN QZ,MA WL,GAO Y,et al.Meta-analysis:therapeutic effect of transcatheter arterial chemoembolization combined w i t h c o m p o u n d k u s h e n i n j e c t i o n i n h e p a t o c e l l u l a r carcinoma[J].African journal of traditional,complementary,and alternative medicines,2011,9(2):178-88.
- [8]范文轩,王三虎,黄瑞,等.四磨汤口服液治疗原发性肝癌介入化疗栓塞术后胃肠功能障碍41例临床观察[J].中国中西医结合消化杂志,2016(8):632-633.
- [9]卢永华.穴位贴敷治疗肝癌介入治疗引起的呕吐腹痛98例效果分析[J].内蒙古中医药,2016(10):76.
- [10]张超,胡应琼.“止吐膏”穴位贴敷防治肝癌介入术后患者恶心呕吐临床观察[J].中国中医急症,2015(3):499-501.
- [11]房济刚.耳穴压豆联合生姜敷脐防治肝癌介入化疗后恶心呕吐的临床观察[J].中国医药指南,2012(18):632-633.
- [12]徐拥建,陈文林,张云城,等.扶正返真汤治疗肝癌介入术后发生不良反应患者的效果评价[J].中国现代药物应用,2017(6):37-38.
- [13]崔德利,黄小兵.香砂六君子汤对原发性肝癌介入术后患者肝功能的影响[J].中医药导报,2015(16):39,45.
- [14]林靖.参桃软肝片治疗肝癌病的临床观察及保肝的实验研究[D].广州:广州中医药大学,2016.
- [15]关丽云,曲金荣,王青山.芪胶生白胶囊防治原发性肝癌介入术后骨髓抑制50例[J].中国药业,2015(18):108-109.
- [16]韩伍龙,袁春樱,张婷素.复方苦参注射液联合介入化疗治疗原发性肝癌的疗效观察及其对免疫功能的影响[J].中国中医药科技,2012,19(1):61-62.
- [17]叶书林,曾普华,郜文辉,等.八宝丹胶囊联合鸦胆子油乳介入治疗湿热聚毒型原发性肝癌的临床研究[J].湖南中医杂志,2016,32(10):1-4.
- [18]曲金荣,王青山,代婧,等.蟾酥注射液对原发性肝癌介入术后不良反应的防治作用[J].疑难病杂志,2012,11(4):294-295.
- [19]肖青松,刘震宇.清热理气活血汤联合饮食、心理护理干预对肝癌介入术患者疼痛、焦虑症状改善的临床察[J].辽宁中医杂志,2015(1):78-79.
- [20]陈毓秀,李广琪,康军,等.止痛益气汤配合心理干预对肝癌介入治疗中疼痛症状缓解的疗效分析[J].陕西中医,2014(1):55-57.
- [21]乔喜婷,王克穷,闫明亮,等.加味大柴胡汤治疗原发性肝癌患者TACE术后综合征的临床观察[J].中医药导报,2016,22(11):28-31.
- [22]黄东彬,管静.龙葵承气汤内服配合心理干预对肝癌介入治疗患者疼痛和情绪的影响[J].新中医,2014,46(10):156-158.
- [23]林娟英.腕踝针治疗肝癌介入治疗后疼痛36例[J/OL].上海针灸杂志,2014,33(1):60.
- [24]倪雪莉.健脾法对中晚期肝癌介入治疗后免疫功能的影响[J].现代诊断与治疗,2012(12):2141-2142.
- [25]苑天文,温树伟,党之俊,等.金龙胶囊联合介入治疗对原发性肝癌患者免疫功能调节作用的观察[J].中国肿瘤临床,2013,40(18):1116-1118.
- [26]闫向勇,燕忠生,孟庆常,等.活血化瘀健脾法对肝癌患者介入治疗后免疫功能及生活质量影响的研究[J].世界中西医结合杂志,2012,7(5):410-412.
- [27]李琳慧,田劲猛.康艾注射液对介入手术后晚期原发性肝癌患者免疫功能的影响[J].内蒙古中医药,2016,35(2):105-106.
- [28]陆运鑫,卢旭全,吴发胜,等.祛毒化瘀消积方对中晚期原发性肝癌介入治疗后患者生存期和生活质量的影响[J].新中医,2016(9):153-155.
- [29]王小璞,赵昌林,郑丹如.榄香烯注射液联合TACE治疗晚期原发性肝癌疗效观察[J].新中医,2017,49(5):87-90.
- [30]寇小妮,郝明霞,解新科,等.八珍汤在原发性肝癌介入治疗后的应用[J].现代肿瘤医学,2016(18):2920-2922.
- [31]党芸芝.裴氏软肝消痞丸对原发性肝癌介入术后患者无进展生存期和生存质量的影响[D].兰州:甘肃中医药大学,2016.
- [32]MA X,LI RS,WANG J,et al.The Therapeutic Efficacy and Safety of Compound Kushen Injection Combined with Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma:An Update Systematic Review and Meta-Analysis[J].Frontiers in pharmacology,2016(7):70.